Back to Journals » OncoTargets and Therapy » Volume 16

LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway [Retraction]

Authors Song X, Xu X, Ren X, Ruan X, Wang Y, Yao TT

Received 20 April 2023

Accepted for publication 20 April 2023

Published 21 April 2023 Volume 2023:16 Pages 281—282

DOI https://doi.org/10.2147/OTT.S418024



Song X, Xu X, Ren X, Ruan X, Wang Y, Yao TT. Onco Targets Ther. 2020;13:8907–8917

At the authors request, the Editor and Publisher of OncoTargets and Therapy are retracting the published article. The authors found errors in the article, including the duplication of images in Figure 3. Specifically,

  • The image used for Figure 3A, HCCLM3, Vector, was duplicated with the image for Figure 3B, HCCLM3, Control.

The authors informed the journal that they were unable to provide adequate data to verify the findings and requested a retraction. The editor agreed with this decision.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.